Mykoplazmowe zapalenie płuc u świń - choroba ważna i aktualna

• Autorzy: Tarasiuk K.

Warianty tytułu

EN

Mycoplasmal pneumonia of swine: Update and importance of the disease

• Języki publikacji: PL

Abstrakty

EN

The paper provides an overview of updated knowledge on this common disease with a strong impact on pig production efficiency. Mycoplasma hyopneumoniae (Mhp), the etiologic agent of the condition, is the smallest self-replicating bacteria, distinguished from most other bacteria by the lack of a cell wall. Colonization of the respiratory cilia is a unique feature of Mhp, which results in a persistent presence of Mhp in the airways and creates a population of infected asymptomatic animals that continually expose other pigs to infection. The economic consequences of a long-term persistence of infection within the herd include a chronic reduction in feed efficiency and increased opportunity for co-infection with other respiratory pathogens, leading to PRDC (porcine respiratory disease complex) syndrome. Chronic Mhp infection in the form of a respiratory disease with high morbidity and low mortality has been estimated to affect up to 70% of pigs worldwide. Diagnostic tools include clinical diagnosis, examination of gross lesions and histopathology. Mycoplasma hyopneumoniaespecific laboratory tests are critical to identify asymptomatic carriers or to detect antibodies as a sign of endemic infection. Tools that demonstrate the presence of Mhp rely on visualizing the organism (culture, FIA) or on detection of nucleic acid (PCR) or antigen specific for that pathogen (ELISA). Control of Mycoplasma hyopneumoniae has been attempted by several widely practiced methods. These include sow vaccination programmes, early vaccination of suckling piglets, use of antibiotics at peak transmission times, introduction of piglet flow in the all-in/all-out system and a segregated system of pig production. Several Mhp elimination protocols have been developed and can be implemented to eradicate this pathogen from the herd. One of them is a partial depopulation procedure, which consists in depopulation of pigs below 9 months of age. The other animals are subjected to medication.

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2020
• Tom: 76
• Numer: 03
• Opis fizyczny: s.150-154,bibliogr.

Twórcy

autor

Tarasiuk K.

• Uniwersyteckie Centrum Medycyny Weterynaryjnej UJ-UR w Krakowie, Al. Mickiewicza 24/28, 30-059 Kraków

Bibliografia

• 1. Arsenakis I., Maes D.: Diagnozowanie chorób układu oddechowego i strategie szczepień przeciwko Mycoplasma hyopneumoniae. Monografia, Materiały XXII Miedzynarodowej Konferencji Naukowej „Zdrowie – czynnik decydujący o konkurencyjności produkcji świń”, Puławy 2017, s. 52-58.
• 2. Bates J.: The use of antemortem tracheobronchial mucus collection technique for Mycoplasma hyopneuminiae. Proc. 44th Annual Meeting Am. Assoc. Swine Veterinarians, Orlando, Florida 2015.
• 3. Bandrick M., Pieters M., Pijoan C., Baidoo S. K., Molitor T. W.: Effect of cross-fostering on transfer of maternal immunity to Mycoplasma hyopneumoniae to piglets. Vet. Rec. 2011, 168, 100.
• 4. Bandrick M., Pieters M., Pijoan C., Molitor T. W.: Passive transfer of maternal Mycoplasma hyopneumoniae specific cellular immunity to piglets. Clin. Vac. Immunol. 2008, 15, 540-543.
• 5. Calsamiglia M., Collins J. E., Pijoan C.: Correlation between the presence of enzootic pneumonia lesions and detection of Mycoplasma hyopneumoniae in bronchial swabs by PCR. Vet. Microbiol. 2000, 76, 299-303.
• 6. Deblanc C., Robert F., Pinard T.: Pre-infection of pigs with Mycoplasma hyopneumoniae induces oxidative stress that influences outcomes of a subsequent infection with a swine influenza virus of H1N1 subtype. Vet. Microbiol. 2013, 162, 643-651.
• 7. Dee S., Otake S., Oliveira S., Deen J.: Evidence of long distance airborne transport of porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae. Vet. Res. 2009, 40, 39.
• 8. Desrosiers R.: A review of some aspects of the epidemiology, diagnosis, and control of Mycoplasma hyopneumoniae infections. J. Swine Health Prod. 2001, 9, 233-237.
• 9. Diaz E. F., Chevez J. R., Angulo J. R.: Using sow mass vaccination mycoplasma protocols for the control of Mycoplasma hyopneumoniae. Proc. of the 19th International Pig Veterinary Society Congress, Copenhagen, Denmark 2007, p. 136.
• 10. Dors A., Czyżewska E., Kwit K., Pejsak Z.: Seroprevalence of important swine pathogens in Polish farms. Proceedings of the 22th International Pig Veterinary Society Congress, Jeju, Korea 2012, 362.
• 11. Dos Santos L. F., Sreevatsan S., Torremorell M.: Genotype distribution of Mycoplasma hyopneumoniae in swine herds from different geographical regions. Vet. Microbiol. 2015, 175, 374-381.
• 12. Drexler C. S., Witvliet M. H., Raes M.: Efficacy of combined porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae vaccination in piglets. Vet. Rec. 2010, 166, 70-74.
• 13. Fablet C., Marois C., Kobisch M.: Estmation of the sensitivity of four sampling methods for Mycoplasma hyopneumoniae detection in live pigs using a Bayesian approach. Vet. Microbiol. 2010, 143, 238-245.
• 14. Fano E., Pijoan C., Dee S.: Effect of Mycoplasma hyopneumoniae colonization at weaning on disease severity in growing pigs. Can. J. Vet. Res. 2007, 71, 195--200.
• 15. Greiner L., Connor J. F., Lowe J. F.: Comparison of Mycoplasma hyopneumoniae vaccination. Proceedings of the 42nd Annual Meeting Am. Assoc. Swine Veterinarians Phoenix, Arizona 2011, 245-248.
• 16. Hsu T., Minion F. C.: Identification of the cilium binding epitope of the Mycoplasma hyopneumoniae P97 adhesin. Infect. Immun. 1998, 66, 4762-4766.
• 17. Maes D.: Mycoplasma hyopneumoniae infections in pigs: update on epidemiology and control. Proc. of the 21st International Pig Veterinary Society Congress Vancouver, Canada 2010, 30-35.
• 18. Maes D., Segales J., Meyns T., Sibila M., Pieters M., Haesebrouck F.: Control of Mycoplasma hyopneumoniae infections in pigs. Vet. Microbiol. 2008, 126, 297-309.
• 19. Nathues H., Fournie G., Wieland B.: Individual risk factors for Mycoplasma hyopneumoniae infections in suckling pigs at the age of weaning. Acta. Vet. Scand. 2013, 55, 44.
• 20. Pejsak Z., Truszczyński M.: Choroby układu oddechowego świń – terapia przyczynowa i objawowa. Życie Wet. 2017, 92, 365-368.
• 21. Pieters M., Cline G. S., Payne B. J.: Intra-farm risk factors for Mycoplasma hyopneumoniae colonization at weaning age. Vet. Microbiol. 2014, 172, 575-580.
• 22. Pieters M., Fano E., Pijoan C., Dee S.: An experimental model to evaluate Mycoplasma hyopneumoniae transmission from asymptomatic carriers to unvaccinated and vaccinated sentinel pigs. Can. J. Vet. Res. 2010, 74, 157-160.
• 23. Pieters M., Rovira A.: Comparison of various sample types for detection of Mycoplasma hyopneumoniae in recently infected pigs. Proc. Allen D. Leman Swine Conference, Minneapolis, Minnesota 2013, 75-76.
• 24. Rautiainen E., Virtala A. M., Wallgren P.: Varying effects of infections with Mycoplasma hyopneumoniae on the weight gain recorded in three different multisource fattening pig herds. J. Vet. Med. B Infect. Dis. Vet. Public Health 2000, 47, 461-469.
• 25. Razin S., Yogev D., Naoth Y.: Molecular biology and pathogenicity of mycoplasmas. Microbiol. Mol. Biol. Rev. 1998, 62, 1094-1156.
• 26. Sibila M., Fort M., Nofrarias M.: Simultaneous porcine circovirus type 2 and Mycoplasma hyopneumoniae co-inoculation does not potentiate disease in conventional pigs. J. Comp. Pathol. 2012, 147, 285-295.
• 27. Strait E. L., Madsen M. L., Minion F. C., Christopher-Hennings J., Dammen M., Jones K. R., Thacker E. L.: Real-time PCR assays to address genetic diversity among strains of Mycoplasma hyopneumoniae. J. Clin. Microbiol. 2008, 46, 2491-2498.
• 28. Simionatto S., Marchioro S. B., Maes D., Dellagostin O. A.: Mycoplasma hyopneumoniae: From disease to vaccine development. Vet. Microbiol. 2013, 165, 234-242.
• 29. Tarasiuk K., Karbowiak S., Rab K.: Eradication of Mycoplasma hyopneumoniae from farrow to finish farm using partial depopulation. Proc. A.D. Leman Swine Conference, St Paul, Minnesota 2008, p. 24.
• 30. Tarasiuk K., Starzewski M.: Eradication of Mycoplasma hyopneumoniae from AI stud. Proc. IPVS Congress, Cancun, Mexico 2014, p. 28.
• 31. Thacker E. L., Halbur P. G., Ross R. F.: Mycoplasma hyopneumoniae potentiation of porcine reproductive and respiratory syndrome virus induced pneumonia. J. Clin. Microbiol. 1999, 37, 620-627.
• 32. Thacker E. L., Minion F. Ch.: Mycoplasmosis, [w:] J. J. Zimmermann, L. A. Karriker, A. Ramirez, K. J. Schwartz, G. W. Stevenson (ed.): Diseases of Swine, 10th ed. John Wiley & Sons, Inc. USA 2012, 779-797.
• 33. Thacker E. L., Thacker B. J., Wolff.: Efficacy of a chlortetracycline feed additive in reducing pneumonia and clinical signs induced by experimental Mycoplasma hyopneumoniae challenge. J. Swine Health Prod. 2006, 14, 140-144.
• 34. Truszczyński M., Pejsak Z.: Mykoplazmy i mykoplazmozy świń. Życie Wet. 2015, 90, 94-97.
• 35. Truszczyński M., Pejsak Z.: Zarządzanie stadem, metafilaktyka i szczepionki przeciw zakażeniom Mycoplasma hyopneumoniae u świń. Życie Wet. 2012, 87, 655-659.
• 36. Vicca J., Stakenborg T., Maes D., Butaye P., Peters J., de Kruif A., Haesebrouck F.: Evaluation of virulence of Mycoplasma hyopneumoniae field isolates. Vet. Microbiol. 2003, 97, 177-190.
• 37. Villarreal I., Maes D., Vranck K., Calus D., Pasmans F., Haesebrouck F.: Effect of vaccination of pigs against experimental infection with high and low virulence Mycoplasma hyopneumoniae strains. Vaccine 2011, 29, 1731-1735.
• 38. Vranck K., Maes D., Calus D.: Multiple-locus variable number tandem repeat analysis is a suitable tool for differentiation of Mycoplasma hyopneumoniae strains without cultivation. J. Clin. Microbiol. 2011, 49, 2020-2023.

Identyfikatory

DOI

10.21521/mw.6375